Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.

Conditions

• Non Small Cell Lung Cancer
• EGFR Gene Mutation

Interventions

• DRUG: Osimertinib
• DRUG: Aspirin

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University